KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Non-cash Items (2016 - 2019)

NovoCure (NVCR) has disclosed Non-cash Items for 5 consecutive years, with $4.3 million as the latest value for Q2 2019.

  • Quarterly Non-cash Items fell 27.0% to $4.3 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Jun 2019, down 27.0% year-over-year, with the annual reading at $287.7 million for FY2018, 4402.57% up from the prior year.
  • Non-cash Items hit $4.3 million in Q2 2019 for NovoCure, down from $5.9 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $287.7 million in Q4 2018 to a low of $4.3 million in Q2 2019.
  • Historically, Non-cash Items has averaged $25.7 million across 5 years, with a median of $6.0 million in 2018.
  • Biggest five-year swings in Non-cash Items: tumbled 68.53% in 2017 and later surged 4402.57% in 2018.
  • Year by year, Non-cash Items stood at $5.2 million in 2015, then skyrocketed by 293.2% to $20.3 million in 2016, then crashed by 68.53% to $6.4 million in 2017, then soared by 4402.57% to $287.7 million in 2018, then plummeted by 98.49% to $4.3 million in 2019.
  • Business Quant data shows Non-cash Items for NVCR at $4.3 million in Q2 2019, $5.9 million in Q1 2019, and $287.7 million in Q4 2018.